BioLife Solutions (BLFS)
(Real Time Quote from BATS)
$20.76 USD
-0.13 (-0.62%)
Updated Aug 5, 2025 03:24 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, BioLife Solutions, Inc. has a PEG ratio of 23.79 compared to the Medical - Products industry's PEG ratio of 2.11.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BLFS 20.76 -0.13(-0.62%)
Will BLFS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BLFS based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BLFS
Ensign Group Boosts U.S. Presence With Idaho and Texas Facility Buyouts
Encompass Health Plans a 50-Bed Unit to Better Serve North Las Vegas
BLFS: What are Zacks experts saying now?
Zacks Private Portfolio Services
How Much Upside is Left in BioLife Solutions (BLFS)? Wall Street Analysts Think 41.72%
EHC Opens Rehabilitation Unit in Fort Myers, Boosts Florida Footprint
Can BioLife Solutions (BLFS) Climb 30.68% to Reach the Level Wall Street Analysts Expect?
Other News for BLFS
BioLife Solutions Inc (BLFS) Announces Strategic Investment in Pluristyx | BLFS stock news
BioLife Solutions (BLFS) Invests in Pluristyx with Convertible Notes
BioLife Solutions Makes Strategic Investment in Pluristyx | BLFS Stock News
BioLife Solutions purchases $2M of convertible notes in Pluristyx
BioLife Solutions Inc (BLFS) Announces Q2 2025 Financial Results Release Date | BLFS stock news